Platelet distribution width as a prognostic factor in patients with COPD – pilot study

References

• BarnesPJThe cytokine network in chronic obstructive pulmonary diseaseAm J Respir Cell Mol Biol200941663163819717810
   PubMed Web of Science ®Google Scholar
• AgustiAGCOPD, a multicomponent disease: implications for managementRespir Med200599667068215878483
   PubMed Web of Science ®Google Scholar
• BhowmikASeemungalTASapsfordRJWedzichaJARelation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbationsThorax200055211412010639527
   PubMed Web of Science ®Google Scholar
• BucchioniEKharitonovSAAllegraLBarnesPJHigh levels of interleukin-6 in the exhaled breath condensate of patients with COPDRespir Med200397121299130214682411
   PubMed Web of Science ®Google Scholar
• GessnerCScheibeRWötzelMExhaled breath condensate cytokine patterns in chronic obstructive pulmonary diseaseRespir Med200599101229124016140223
   PubMed Web of Science ®Google Scholar
• Emami ArdestaniMZaerinORole of serum interleukin 6, albumin and C-reactive protein in COPD PatientsTanaffos201514213414026528368
   PubMedGoogle Scholar
• YasudaNGotohKMinatoguchiSAn increase of soluble Fas, an inhibitor of apoptosis, associated with progression of COPDRespir Med19989289939999893764
   PubMed Web of Science ®Google Scholar
• TempletonAJAceOMcNamaraMGPrognostic role of platelet to lymphocyte ratio in solid tumors: a systematic review and meta-analysisCancer Epidemiol Biomark Prev201423712041212
   PubMed Web of Science ®Google Scholar
• OhsugiYRecent advances in immunopathophysiology of interleukin-6: an innovative therapeutic drug, tocilizumab (recombinant humanized anti-human interleukin-6 receptor antibody), unveils the mysterious etiology of immune-mediated inflammatory diseasesBiol Pharm Bull200730112001200617978466
   PubMed Web of Science ®Google Scholar
• ImaiTKoikeKKuboTInterleukin-6 supports human megakaryocytic proliferation and differentiation in vitroBlood1991788196919741912578
   PubMed Web of Science ®Google Scholar
• LippitzBECytokine patterns in patients with cancer: a systematic reviewLancet Oncol2013146e218e22823639322
   PubMed Web of Science ®Google Scholar
• KlingerMHJelkmannWRole of blood platelets in infection and inflammationJ Interferon Cytokine Res200222991392212396713
   PubMed Web of Science ®Google Scholar
• NordingHMSeizerPLangerHFPlatelets in inflammation and atherogenesisFront Immunol201569825798138
   PubMed Web of Science ®Google Scholar
• KarshovskaEWeberCvon HundelshausenPPlatelet chemokines in health and diseaseThromb Haemost2013110589490223783401
   PubMed Web of Science ®Google Scholar
• MeiJLiuYDaiNCXCL5 regulates chemokine scavenging and pulmonary host defense to bacterial infectionImmunity201033110611720643340
   PubMed Web of Science ®Google Scholar
• SeizerPMayAEPlatelets and matrix metalloproteinasesThromb Haemost2013110590390923864155
   PubMed Web of Science ®Google Scholar
• RahmanMRollerJZhangSMetalloproteinases regulate CD40L shedding from platelets and pulmonary recruitment of neutrophils in abdominal sepsisInflamm Res201261657157922349180
   PubMed Web of Science ®Google Scholar
• MayAEKälschTMassbergSHerouyYSchmidtRGawazMEngagement of glycoprotein IIb/IIIa (alpha(IIb)beta3) on platelets upregulates CD40L and triggers CD40L-dependent matrix degradation by endothelial cellsCirculation2002106162111211712379582
   PubMed Web of Science ®Google Scholar
• Skjøt-ArkilHClausenRENguyenQHMeasurement of MMP-9 and -12 degraded elastin (ELM) provides unique information on lung tissue degradationBMC Pulm Med2012123422818364
   PubMed Web of Science ®Google Scholar
• IlumetsHRytiläPDemedtsIMatrix metalloproteinases -8, -9 and -12 in smokers and patients with stage 0 COPDInt J Chron Obstruct Pulmon Dis20072336937918229576
   PubMedGoogle Scholar
• BrajerBBatura-GabryelHNowickaAKuznar-KaminskaBSzczepanikAConcentration of matrix metalloproteinase-9 in serum of patients with chronic obstructive pulmonary disease and a degree of airway obstruction and disease progressionJ Physiol Pharmacol200859Suppl 6145152
   PubMedGoogle Scholar
• KwiatkowskaSNowetaKZiebaMNowakDBialasiewiczPEnhanced exhalation of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in patients with COPD exacerbation: a prospective studyRespiration201284323124122832426
   PubMed Web of Science ®Google Scholar
• NavratilovaZZatloukalJKriegovaEKolekVPetrekMSimultaneous up-regulation of matrix metalloproteinases 1, 2, 3, 7, 8, 9 and tissue inhibitors of metalloproteinases 1, 4 in serum of patients with chronic obstructive pulmonary diseaseRespirology20121761006101222591289
   PubMed Web of Science ®Google Scholar
• Rahimi-RadMHSoltaniSRabieepourMRahimiradSThrombocytopenia as a marker of outcome in patients with acute exacerbation of chronic obstructive pulmonary diseasePneumonol Alergol Pol201583534835126378995
   PubMedGoogle Scholar
• HarrisonMTShortPWilliamsonPASinganayagamAChalmersJDSchembriSThrombocytosis is associated with increased short and long term mortality after exacerbation of chronic obstructive pulmonary disease: a role for antiplatelet therapy?Thorax201469760961524743560
   PubMed Web of Science ®Google Scholar
• AzabBShahNAkermanMMcGinnJTJrValue of platelet/lymphocyte ratio as a predictor of all-cause mortality after non-ST-elevation myocardial infarctionJ Thromb Thrombolysis201234332633422466812
   PubMed Web of Science ®Google Scholar
• SunbulMGerinFDurmusENeutrophil to lymphocyte and platelet to lymphocyte ratio in patients with dipper versus non-dipper hypertensionClin Exp Hypertens201436421722123786430
   PubMed Web of Science ®Google Scholar
• LiuWYLinSGWangLRPlatelet-to-lymphocyte ratio: a novel prognostic factor for prediction of 90-day outcomes in critically ill patients with diabetic ketoacidosisMedicine (Baltimore)2016954e259626825908
   PubMed Web of Science ®Google Scholar
• AsherVLeeJInnamaaABaliAPreoperative platelet lymphocyte ratio as an independent prognostic marker in ovarian cancerClin Transl Oncol201113749950321775277
   PubMed Web of Science ®Google Scholar
• BhattiIPeacockOLloydGLarvinMHallRIPreoperative hematologic markers as independent predictors of prognosis in resected pancreatic ductal adenocarcinoma: neutrophil-lymphocyte versus platelet-lymphocyte ratioAm J Surg2010200219720320122680
   PubMed Web of Science ®Google Scholar
• CarruthersRThoLMBrownJKakumanuSMcCartneyEMcDonaldACSystemic inflammatory response is a predictor of outcome in patients undergoing preoperative chemoradiation for locally advanced rectal cancerColorectal Dis20121410e701e70722731833
   PubMed Web of Science ®Google Scholar
• DuttaSCrumleyABFullartonGMHorganPGMcMillanDCComparison of the prognostic value of tumour and patient related factors in patients undergoing potentially curative resection of gastric cancerAm J Surg2012204329429922444831
   PubMed Web of Science ®Google Scholar
• DuttaSCrumleyABFullartonGMHorganPGMcMillanDCComparison of the prognostic value of tumour- and patient-related factors in patients undergoing potentially curative resection of oesophageal cancerWorld J Surg20113581861186621538187
   PubMed Web of Science ®Google Scholar
• FoxPHudsonMBrownCMarkers of systemic inflammation predict survival in patients with advanced renal cell cancerBr J Cancer2013109114715323778526
   PubMed Web of Science ®Google Scholar
• RaungkaewmaneeSTangjitgamolSManusirivithayaSSrijaipracharoenSThavaramaraTPlatelet to lymphocyte ratio as a prognostic factor for epithelial ovarian cancerJ Gynecol Oncol201223426527323094130
   PubMed Web of Science ®Google Scholar
• SmithRABosonnetLRaratyMPreoperative platelet-lymphocyte ratio is an independent significant prognostic marker in resected pancreatic ductal adenocarcinomaAm J Surg2009197446647218639229
   PubMed Web of Science ®Google Scholar
• WangDSLuoHYQiuMZComparison of the prognostic values of various inflammation based factors in patients with pancreatic cancerMed Oncol20122953092310022476808
   PubMed Web of Science ®Google Scholar
• WangDSRenCQiuMZComparison of the prognostic value of various preoperative inflammation-based factors in patients with stage III gastric cancerTumour Biol201233374975622198641
   PubMedGoogle Scholar
• LiXChenZHXingYFPlatelet-to-lymphocyte ratio acts as a prognostic factor for patients with advanced hepatocellular carcinomaTumour Biol20153642263226925409616
   PubMedGoogle Scholar
• TianXZengFWuDPlatelet-to-lymphocyte ratio: a prognostic factor for patients with advanced hepatocellular carcinoma?Tumour Biol20153674935493626025113
   PubMedGoogle Scholar
• BancroftAJAbelEWMclarenMBelchJJMean platelet volume is a useful parameter: a reproducible routine method using a modified Coulter thrombocytometerPlatelets200011737938711132104
   PubMed Web of Science ®Google Scholar
• GasparyanAYAyvazyanLMikhailidisDPKitasGDMean platelet volume: a link between thrombosis and inflammation?Curr Pharm Des2011171475821247392
   PubMed Web of Science ®Google Scholar
• KimDSLeeJKimSHKimSMLeeMGMean platelet volume is elevated in patients with psoriasis vulgarisYonsei Med J201556371271825837177
   PubMed Web of Science ®Google Scholar
• KisacikBTufanAKalyoncuUMean platelet volume (MPV) as an inflammatory marker in ankylosing spondylitis and rheumatoid arthritisJoint Bone Spine200875329129418403245
   PubMed Web of Science ®Google Scholar
• WangRTLiJYCaoZGLiYMean platelet volume is decreased during an acute exacerbation of chronic obstructive pulmonary diseaseRespirology20131881244124823786593
   PubMed Web of Science ®Google Scholar
• BessmanJDWilliamsLJGilmerPRJrPlatelet size in health and hematologic diseaseAm J Clin Pathol19827821501536954850
   PubMed Web of Science ®Google Scholar
• BaeMHLeeJHYangDHParkHSChoYChaeSCWhite blood cell, hemoglobin and platelet distribution width as short-term prognostic markers in patients with acute myocardial infarctionJ Korean Med Sci201429451952624753699
   PubMed Web of Science ®Google Scholar
• FanZPanJZhangYMean platelet volume and platelet distribution width as markers in the diagnosis of acute gangrenous appendicitisDis Markers2015201554201326688600
   PubMed Web of Science ®Google Scholar
• AydoganAAkkucukSAricaSThe analysis of mean platelet volume and platelet distribution width levels in appendicitisIndian J Surg201577Suppl 2495500
   Web of Science ®Google Scholar
• KokluEYukselIOArslanSPredictors of symptom development in intermediate carotid artery stenosis: mean platelet volume and platelet distribution widthAngiology201667762262926514416
   PubMed Web of Science ®Google Scholar
• YilmazMCimilliGSaritemurMDiagnostic accuracy of neutrophil/lymphocyte ratio, red cell distribution width and platelet distribution width in ovarian torsionJ Obstet Gynaecol201636221822226467739
   PubMedGoogle Scholar
• KaratekeAKurtRKBaloğluARelation of platelet distribution width (PDW) and platelet crit (PCT) to preeclampsiaGinekol Pol201586537237526117976
   PubMed Web of Science ®Google Scholar
• ZhengYGYangTXiongCMPlatelet distribution width and mean platelet volume in idiopathic pulmonary arterial hypertensionHeart Lung Circ201524656657225573235
   PubMed Web of Science ®Google Scholar
• OzyurtluFYavuzVCetinNAcetHAyhanEIsikTThe association between coronary slow flow and platelet distribution width among patients with stable angina pectorisPostępy Kardiol Interwencyjnej201410316116525489301
   PubMed Web of Science ®Google Scholar
• AdamGKocakEÖzkanAEvaluation of platelet distribution width and mean platelet volume in patients with carotid artery stenosisAngiology201566437537825313243
   PubMed Web of Science ®Google Scholar
• BeklerAOzkanMTTenekeciogluEIncreased platelet distribution width is associated with severity of coronary artery disease in patients with acute coronary syndromeAngiology201566763864325112777
   PubMed Web of Science ®Google Scholar
• RechcińskiTJasińskaAForyśJPrognostic value of platelet indices after acute myocardial infarction treated with percutaneous coronary interventionCardiol J201320549149824469872
   PubMed Web of Science ®Google Scholar
• HansellALWalkJASorianoJBWhat do chronic obstructive pulmonary disease patients die from? A multiple cause coding analysisEur Respir J200322580981414621089
   PubMed Web of Science ®Google Scholar
• ZielinskiJMacNeeWWedzichaJCauses of death in patients with COPD and chronic respiratory failureMonaldi Arch Chest Dis199752143479151520
   PubMedGoogle Scholar
• MillerMRHankinsonJBrusascoVStandardisation of spirometryEur Respir J200526231933816055882
   PubMed Web of Science ®Google Scholar
• MillerMRCrapoRHankinsonJGeneral considerations for lung function testingEur Respir J200526115316115994402
   PubMed Web of Science ®Google Scholar
• WangerJClausenJLCoatesAStandardisation of the measurement of lung volumesEur Respir J200526351152216135736
   PubMed Web of Science ®Google Scholar
• MacintyreNCrapoROViegiGStandardisation of the single-breath determination of carbon monoxide uptake in the lungEur Respir J200526472073516204605
   PubMed Web of Science ®Google Scholar
• BickRodger LMuranoGenesioPhysiology of hemostasisDisorders of Thrombosis and Hemostasis: Clinical and Laboratory PracticeLippincott Williams & Wilkins20026
   Google Scholar
• WangMZhangJJiQEvaluation of platelet distribution width in chronic obstructive pulmonary disease patients with pulmonary embolismBiomark Med20161058759626567584
   PubMed Web of Science ®Google Scholar
• KaradenizGAktoğuSErerOFPredictive value of platelet-to-lymphocyte ratio in exacerbation of chronic obstructive pulmonary diseaseBiomark Med201610770171027339097
   PubMed Web of Science ®Google Scholar
• SteiropoulosPPapanasNNenaEMean platelet volume and platelet distribution width in patients with chronic obstructive pulmonary disease: the role of comorbiditiesAngiology201364753553923052724
   PubMed Web of Science ®Google Scholar
• EkströmMPHermanssonABStrömKEEffects of cardiovascular drugs on mortality in severe chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2013187771572023328521
   PubMed Web of Science ®Google Scholar
• MakhloufHASadekSHNafadyAAPlatelet function in diabetic and nondiabetic patients with chronic obstructive pulmonary disease: a case control studyClin Respir J201610.1111/crj.12477
   Web of Science ®Google Scholar
• QuanjerPWeinerDJPrettoJJBrazzaleDJBorosPWMeasurement of FEF25%–75% and FEF75% does not contribute to clinical decision makingEur Respir J20144341051105824072211
   PubMed Web of Science ®Google Scholar
• WhitePSpirometry and peak expiratory flow in the primary care management of COPDPrim Care Respir J20041315816701628
   PubMedGoogle Scholar